Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Eton Pharmaceuticals, Inc. | Chief Financial Officer | Stock Option (Right to buy) | 375K | Feb 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ETON | Eton Pharmaceuticals, Inc. | Feb 13, 2024 | 1 | $0 | 4 | Feb 15, 2024 | Chief Financial Officer |
ETON | Eton Pharmaceuticals, Inc. | Mar 3, 2023 | 1 | $0 | 4 | Mar 3, 2023 | Chief Financial Officer |
ETON | Eton Pharmaceuticals, Inc. | Jul 12, 2022 | 1 | $0 | 4 | Jul 18, 2022 | Chief Financial Officer |
ETON | Eton Pharmaceuticals, Inc. | Apr 11, 2022 | 0 | $0 | 3 | Apr 14, 2022 | Chief Financial Officer |